InvestorsHub Logo
icon url

farrell90

10/31/20 2:41 PM

#330763 RE: Jhawker #330759

IPIX has stated it may study Brilacidin against a variety of pulmonary diseases. Possible targets are asthma, COPD, chronic bronchitis,bronchiectasis, cystic fibrosis, pulmonary fibrosis and others.

GLTA Farrell